Recessive truncating titin gene, TTN , mutations presenting as centronuclear myopathy
Authors:
- Ozge Ceyhan-BirsoyOCOzge Ceyhan-Birsoy
- Pankaj B. AgrawalPAPankaj B. Agrawal
- Carlos HidalgoCHCarlos Hidalgo
- Klaus Schmitz-AbeKSKlaus Schmitz-Abe
- Elizabeth T. DeCheneEDElizabeth T. DeChene
- Lindsay C. SwansonLSLindsay C. Swanson
- Rachel SoemediRSRachel Soemedi
- Nasim VasliNVNasim Vasli
- Susan T. IannacconeSISusan T. Iannaccone
- Perry B. ShiehPSPerry B. Shieh
- Natasha ShurNSNatasha Shur
- Jane M. DennisonJDJane M. Dennison
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (14) , 1205-1214
Abstract
Objective: To identify causative genes for centronuclear myopathies (CNM), a heterogeneous group of rare inherited muscle disorders that often present in infancy or early life with weakness and hypotonia, using next-generation sequencing of whole exomes and genomes. Methods: Whole-exome or -genome sequencing was performed in a cohort of 29 unrelated patients with clinicopathologic diagnoses of CNM or related myopathy depleted for cases with mutations of MTM1, DNM2, and BIN1. Immunofluorescence analyses on muscle biopsies, splicing assays, and gel electrophoresis of patient muscle proteins were performed to determine the molecular consequences of mutations of interest. Results: Autosomal recessive compound heterozygous truncating mutations of the titin gene, TTN, were identified in 5 individuals. Biochemical analyses demonstrated increased titin degradation and truncated titin proteins in patient muscles, establishing the impact of the mutations. Conclusions: Our study identifies truncating TTN mutations as a cause of congenital myopathy that is reported as CNM. Unlike the classic CNM genes that are all involved in excitation-contraction coupling at the triad, TTN encodes the giant sarcomeric protein titin, which forms a myofibrillar backbone for the components of the contractile machinery. This study expands the phenotypic spectrum associated with TTN mutations and indicates that TTN mutation analysis should be considered in cases of possible CNM without mutations in the classic CNM genes.Keywords
This publication has 40 references indexed in Scilit:
- Clinical utility gene card for: Centronuclear and myotubular myopathiesEuropean Journal of Human Genetics, 2012
- Centronuclear MyopathiesSeminars in Pediatric Neurology, 2011
- Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiencyHuman Molecular Genetics, 2009
- “Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathyActa Neuropathologica, 2008
- Centronuclear (myotubular) myopathyOrphanet Journal of Rare Diseases, 2008
- C‐terminal titin deletions cause a novel early‐onset myopathy with fatal cardiomyopathyAnnals of Neurology, 2007
- Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophyProceedings of the National Academy of Sciences, 2007
- Titin and Its associated proteins: the third myofilament system of the sarcomere2005
- Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein TitinThe American Journal of Human Genetics, 2002
- Effects of postmortem aging time, animal age, and sex on degradation of titin and nebulin in bovine longissimus muscleJournal of Animal Science, 1995